Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/1996
09/10/1996US5554637 Use of leflunomide for inhibiting interleukin 1 alpha
09/10/1996US5554623 Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates
09/10/1996US5554621 Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
09/10/1996US5554613 Quinuclidine derivatives, qualene synthase inhibitors, treatment of hypercholesterolemia, atherosclerosis and fungus infections
09/10/1996US5554601 Administering an estrogen compound in the absence of testosterone; treatment of alzheimer*s
09/10/1996US5554599 22-thio vitamin D derivatives
09/06/1996WO1996027006A2 Human vegf-specific antisense oligonucleotides
09/06/1996WO1996026935A1 2-benzyl-3-arylbenzothiophenes
09/06/1996WO1996026730A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment
09/06/1996WO1996026728A2 Use of moxonidine for the treatment of atherosclerosis
09/06/1996WO1996026716A1 Elcatonin controlled release microsphere formulation for treatment of osteoporosis
09/06/1996WO1996026647A1 Supplement for baby infant formula and a method of delivering that supplement
09/06/1996WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/06/1996CA2214134A1 2-benzyl-3-arylbenzothiophenes
09/06/1996CA2213971A1 Supplement for baby infant formula and a method of delivering that supplement
09/06/1996CA2213344A1 Use of acid-sensitive organo-transition metal compounds in cancer treatment
09/06/1996CA2212294A1 Use of moxonidine for the treatment of atherosclerosis
09/04/1996EP0729955A1 2-Benzyl-3-Arylbenzothiophenes useful for the treatment of post-menopausal syndrome
09/04/1996EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
09/04/1996EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
09/04/1996EP0729354A1 Farnesyl derivatives and pharmaceutical compositions containing them
09/04/1996EP0729352A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
09/04/1996CN1130385A Antibiotics 10381V. W. X. Y. Z1, Z2 Pre-B and T
09/04/1996CN1130381A Use of coumarins and carbostyrils as PLAZ inhibitors, new coumarins and carbostyrils, process for prep, the same and medicaments
09/04/1996CN1130186A Ethers substituted by dicycle oxazole and thiazole
09/04/1996CN1130184A New Tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions which contain them
09/04/1996CN1130063A Estogen effect promoting medicine
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
09/03/1996US5552433 Method for lowering serum cholesterol
09/03/1996US5552418 Trisubstituted Naphthylalkylamides
09/03/1996US5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
09/03/1996US5552401 2-benzyl-3-arylbenzothiophenes
09/03/1996US5552396 Bis-indolemaleimide macrocyclic derivatives,
09/03/1996CA2076658C Hyperglycemic compositions
08/1996
08/29/1996WO1996026286A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
08/29/1996WO1996026218A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
08/29/1996WO1996026205A1 Inhibitors of microsomal triglyceride transfer protein and method
08/29/1996WO1996025945A1 ISOFORMS OF HUMAN INTERLEUKIN-1β CONVERTING ENZYME AND METHODS OF USING THE SAME
08/29/1996WO1996025942A1 Cochleate phospholipids in drug delivery
08/29/1996WO1996025939A1 Use of piperine as a bioavailability enhancer
08/29/1996WO1996018737A3 Vectors and viruses for use in gene therapy
08/29/1996WO1996014412A3 cDNA ENCODING A BMP TYPE II RECEPTOR
08/29/1996CA2566828A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
08/29/1996CA2213610A1 Ingap protein involved in pancreatic islet neogenesis
08/29/1996CA2211541A1 Isoforms of human interleukin-1.beta. converting enzyme and methods of using the same
08/28/1996EP0728742A2 Novel retinoids
08/28/1996EP0728147A1 Receptor specific atrial natriuretic peptides
08/28/1996EP0728145A1 Endothelin receptor antagonists
08/28/1996EP0728142A1 Novel antler-derived bone growth factors
08/28/1996EP0728134A1 6-oxo-nucleosides useful as immunosuppressants
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0727999A1 Treatment of immunoregulatory disorders
08/28/1996EP0727947A1 New beverage
08/28/1996EP0305387B2 Insulinotropic hormone
08/28/1996CN1129933A 5-arylindole derivatives
08/27/1996USRE35321 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity
08/27/1996US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity
08/27/1996US5550166 Pinitol and derivatives thereof for the treatment of metabolic disorders
08/27/1996US5550162 N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydro-naphthalene-2-carboxamide derivatives, their preparation and their therapeutic use
08/27/1996US5550156 Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996CA2046345C Functional food
08/25/1996CA2170227A1 Novel retinoids
08/22/1996WO1996025487A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025384A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025171A1 Inhibition of angiogenesis using interleukin-12
08/22/1996WO1996025165A1 Method of lessening the risk of non-vertebral bone fractures
08/22/1996WO1996025160A1 The use of heterocyclic compounds
08/22/1996DE19505100A1 Alk(en)yldicarbonsäurebisester, deren Verwendung sowie Verfahren zu deren Herstellung Alk (en) yldicarbonsäurebisester, their use and processes for their preparation
08/22/1996CA2212996A1 Method of lessening the risk of non-vertebral bone fractures
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2211674A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
08/22/1996CA2211101A1 Materials and methods relating to the regulation of polypeptide production in cells
08/21/1996EP0727211A1 Use of src SH2 specific compounds to treat a bone resorption disease
08/21/1996EP0726954A1 Cntf family antagonists
08/21/1996EP0726901A1 Benzo-fused macrocycles promote release of growth hormone
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726771A1 Desferrioxamine oral delivery system
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726715A1 Psyllium containing snack bars, processes for making these, and uses thereof
08/21/1996EP0636002B1 A salt product and a method for the preparation thereof
08/21/1996EP0584115B1 Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them
08/21/1996EP0517820B1 Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129443A Secondary amines as antidiabetic and antiobesity agents
08/21/1996CN1129442A Benzodiazepine compounds useful as antagonisis of cck or of gastrine
08/21/1996CN1129224A Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
08/21/1996CN1129219A Pharmaceutical compounds
08/21/1996CN1129104A Total parenteral nutrition solution containing water-soluble vitamin B
08/20/1996US5547949 Steroids with pregnane skeleton, pharmaceutical compositions containing them
08/20/1996US5547929 A parenteral composition comprising a soluble phase of a monomeric insulin analog and a solid phase of insulin-neutral protamine hagedorn crystals; provides a rapid onset and prolonged duration of action
08/15/1996WO1996024669A1 Human pancreatic cell lines: developments and uses
08/15/1996WO1996024618A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
08/15/1996WO1996024595A1 New forms of paroxetin hydrochloride
08/15/1996WO1996024370A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
1 ... 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 ... 1298